Workflow
润都股份: 半年报董事会决议公告

Group 1 - The board meeting of Zhuhai Runduo Pharmaceutical Co., Ltd. was held on August 29, 2025, with all 7 directors present, either in person or via communication voting [1] - The board unanimously approved the 2025 semi-annual report, confirming that it accurately reflects the company's actual situation without any false records or significant omissions [1] - The meeting was chaired by Chairman Chen Xinmin and complied with the relevant provisions of the Company Law of the People's Republic of China and the company's articles of association [1] Group 2 - The company disclosed the summary of the 2025 semi-annual report in various financial newspapers and on the website of the China Securities Regulatory Commission [2] - The board's decision and the semi-annual report are available for public review as per the company's disclosure obligations [2]